Serum Institute of India (SII) | Page 6 | The Business Standard

A medical worker receives the AstraZeneca's Covishield coronavirus disease (Covid-19) vaccine in Yangon, Myanmar, after the country received 1.5 million doses of the vaccine manufactured by the Serum Institute of India, January 27, 2021. REUTERS/Shwe Paw Mya Tin

Coronavirus chronicle

Myanmar launches vaccination drive, prioritises frontline healthcare workers

Myanmar received 1.5 million doses of the vaccine manufactured by the Serum Institute of India

Coronavirus chronicle

Saudi Arabia to get AstraZeneca shots in about a week from India

Reena Jani, 34, a health worker, receives the vaccine developed by Oxford/AstraZeneca at Mathalput Community Health Centre, during the coronavirus disease (Covid-19) pandemic, in Koraput, India, January 16, 2021. REUTERS/Danish Siddiqui

Coronavirus chronicle

From factory to faraway village: Behind India's mammoth vaccination drive

File Photo: Small bottles labelled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

Coronavirus chronicle

Covax announces new agreement, plans for first deliveries

Photo: NDTV

Coronavirus chronicle

'No actual vaccine was being produced at that facility': SII CEO

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (Covid-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha/File Photo/File Photo

Coronavirus chronicle

South Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII

Picture: Collected

South Asia

5 killed in fire at Pune's Serum Institute’s Manjri plant

A fire broke out at at a building at the Serum Institute of India in Pune. (Photo: ANI)

World+Biz

Fire at Serum Institute’s plant that produces Covid vaccine

Representational image. Picture: Collected

Coronavirus chronicle

Covid-19 vaccines: Fact sheets in India warn against use in immuno-compromised

A woman walks past a painting of Indian Prime Minister Narendra Modi a day before the inauguration of the Covid-19 vaccination drive on a street in Mumbai, India, January 15, 2021. REUTERS/Francis Mascarenhas

Coronavirus chronicle

India kicks off 'world's largest' vaccination campaign

FILE PHOTO: Vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine, are seen before they are packaged inside a lab at Serum Institute of India, Pune, India, Nov. 30, 2020. REUTERS/Francis Mascarenhas/File Photo

Coronavirus chronicle

Covishield efficacy higher if gap over 28 days, says India’s Serum Institute

Coronavirus chronicle

India's Serum Institute expects WHO emergency approval for AstraZeneca shot soon

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas

Coronavirus chronicle

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses